[go: up one dir, main page]

DK0814813T3 - Anvendelse af penciclovir til behandling af human herpesvirus-8 - Google Patents

Anvendelse af penciclovir til behandling af human herpesvirus-8

Info

Publication number
DK0814813T3
DK0814813T3 DK96907360T DK96907360T DK0814813T3 DK 0814813 T3 DK0814813 T3 DK 0814813T3 DK 96907360 T DK96907360 T DK 96907360T DK 96907360 T DK96907360 T DK 96907360T DK 0814813 T3 DK0814813 T3 DK 0814813T3
Authority
DK
Denmark
Prior art keywords
treatment
penciclovir
herpes virus
human herpes
bioprecursor
Prior art date
Application number
DK96907360T
Other languages
Danish (da)
English (en)
Inventor
Klaus Max Esser
Hodge Richard Anthony Vere
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Application granted granted Critical
Publication of DK0814813T3 publication Critical patent/DK0814813T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96907360T 1995-03-07 1996-03-05 Anvendelse af penciclovir til behandling af human herpesvirus-8 DK0814813T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504497.0A GB9504497D0 (en) 1995-03-07 1995-03-07 Pharmaceuticals
PCT/EP1996/000933 WO1996027378A2 (fr) 1995-03-07 1996-03-05 Utilisation de peniclovir pour le traitement de l'herpesvirus 8 humain

Publications (1)

Publication Number Publication Date
DK0814813T3 true DK0814813T3 (da) 2004-03-22

Family

ID=10770731

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96907360T DK0814813T3 (da) 1995-03-07 1996-03-05 Anvendelse af penciclovir til behandling af human herpesvirus-8

Country Status (22)

Country Link
US (1) US6489330B1 (fr)
EP (1) EP0814813B1 (fr)
JP (2) JPH11501625A (fr)
KR (1) KR19980702833A (fr)
CN (1) CN1138545C (fr)
AT (1) ATE254919T1 (fr)
AU (1) AU701739B2 (fr)
BR (1) BR9607663A (fr)
CA (1) CA2214406C (fr)
CY (1) CY2525B1 (fr)
CZ (1) CZ293470B6 (fr)
DE (1) DE69630876T2 (fr)
DK (1) DK0814813T3 (fr)
ES (1) ES2211949T3 (fr)
GB (1) GB9504497D0 (fr)
HU (1) HU226005B1 (fr)
NO (1) NO317733B1 (fr)
NZ (1) NZ303951A (fr)
PT (1) PT814813E (fr)
TR (1) TR199700921T1 (fr)
WO (1) WO1996027378A2 (fr)
ZA (1) ZA961795B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白(rap)-缀合物对肝病症的治疗
EP2274042A4 (fr) * 2008-04-11 2012-03-14 Epiphany Biosciences Inc Traitement et/ou prévention de la sclérose en plaques
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
EP0182024B1 (fr) * 1984-09-20 1991-04-03 Beecham Group Plc Dérivés de purine et leur utilisation pharmaceutique
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
CA2042931A1 (fr) 1990-05-24 1991-11-25 Robert Zahler Bis(hydroxymethyl)cyclobutylpurines et -pyrimidines fluorees
GB9015051D0 (en) 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment

Also Published As

Publication number Publication date
ES2211949T3 (es) 2004-07-16
PT814813E (pt) 2004-04-30
AU5102296A (en) 1996-09-23
EP0814813A2 (fr) 1998-01-07
EP0814813B1 (fr) 2003-11-26
GB9504497D0 (en) 1995-04-26
CN1138545C (zh) 2004-02-18
NZ303951A (en) 1999-07-29
ATE254919T1 (de) 2003-12-15
HU226005B1 (en) 2008-02-28
DE69630876T2 (de) 2004-09-02
ZA961795B (en) 1996-11-25
US6489330B1 (en) 2002-12-03
WO1996027378A2 (fr) 1996-09-12
NO317733B1 (no) 2004-12-13
KR19980702833A (ko) 1998-08-05
WO1996027378A3 (fr) 1997-01-16
CY2525B1 (en) 2006-02-08
CZ293470B6 (cs) 2004-05-12
CA2214406C (fr) 2010-12-21
NO974101L (no) 1997-09-05
JPH11501625A (ja) 1999-02-09
JP2007297412A (ja) 2007-11-15
AU701739B2 (en) 1999-02-04
HK1004373A1 (en) 1998-11-27
CA2214406A1 (fr) 1996-09-12
BR9607663A (pt) 1998-06-16
CZ283197A3 (cs) 1998-02-18
MX9706759A (es) 1997-11-29
TR199700921T1 (xx) 1998-02-21
DE69630876D1 (de) 2004-01-08
CN1183722A (zh) 1998-06-03
HUP9800272A3 (en) 2000-12-28
HUP9800272A2 (hu) 2000-05-28
NO974101D0 (no) 1997-09-05

Similar Documents

Publication Publication Date Title
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
SE0004101D0 (sv) New use
YU6396A (sh) Kombinacija inhibitora hiv proteaze sa drugim jedinjenjima za terapiju hiv infekcija
MX9806229A (es) Derivados de benzo(c)quinolicina, su preparacion y uso como inhibidores de la 5alfa-reductasas.
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
DK0814813T3 (da) Anvendelse af penciclovir til behandling af human herpesvirus-8
DE10299023I2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
AP9801235A0 (en) Erythromycin derivatives.
CA2207503A1 (fr) Emploi d'agents antiviraux a base d'aminopurine pour le traitement et la prophylaxie d'infections latentes par les herpesvirus
TR199900013T2 (xx) Yeni bile�ikler.
DK0728001T3 (da) Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 6-infektioner
ES2131331T3 (es) Uso de benzotiofenos para la preparacion de un medicamento para reducir la formacion de cicatrices en la curacion de heridas.